How to Apply

UK Myeloma Society
Award of Bursaries to EHA Congress 2024
13-16 June 2024, Madrid

The UK Myeloma Society (UKMS) is pleased to announce that there will be total of 2 bursaries available either virtually or person attend EHA Congress 2024 in Madrid. All applicants must be UK based and must be members of the UK Myeloma Society. If you are not currently a member, please register via our website, a link can be found here. Membership is free.

Applicants must be either the first or last author. Or, if neither, please specifically state your substantial contribution to this work in order to justify the bursary.

Travel grant winners will be selected by a panel of from the UKMS Executive Committee. Please do not apply if you have been awarded a UKMS (formally UKMF) bursary in the last two years. Successful applicants will be required to complete the tasks set out below:

Number of bursaries to be awarded Eligible Group Application CriteriaTasks to be completed if successful  Value of award


Scientists, nurses, pharmacists, clinicians and other investigators submitting an abstract to EHA relevant to MyelomaAbstract submitted to EHA to be forwarded to UKMS
  • Present your abstract at the UKMS Spring Day on Wednesday 20 March 2024 (Central London)
  • Write a review for the UKMS website and e-newsletter by July 2024.
  • Indicate whether virtual or in person attendance at time of accepting bursary.
Up to £900 each

Funding has kindly been provided by the Michael Morley Fund and our Platinum sponsors, Amgen, The Binding Site, GSK, Janssen, Menarini Stemline, who we thank for their continued support. 


All Applications must include a cover letter or e-mail with details of:

  • Name
  • Current position or job title
  • Place of work, with department, address and contact details
  • Please do not apply if you have been awarded a UKMS (formally UKMF) bursary in the last 2 years.
  • Applicants must be either first or last author.
  • It would be helpful to let the judges know if your abstract has been accepted.

Those who are submitting an abstract to EHA Congress and wish to be considered for any of these grants should submit their abstract electronically to Wendy (, by 5pm on Wednesday 6 March 2024. 

All submissions will be judged by a panel of members of the UKMS Executive Committee and applicants will be notified of the outcome of the competition by the end of March 2024 at the latest.

Please note that if you are unable to present your work, then the UKMS reserve the right to withdraw the bursary.

Professor Gordon Cook

Dean of College of Myeloma

Professor of Haematology & Myeloma Studies, Consultant Haematologist

St James Institute of Oncology, Leeds Teaching Hospitals, Leeds, UK

I am a graduate of the University of Glasgow School of Medicine. I received my higher professional training in haematology in the West of Scotland. After completion of my PhD, I was appointed as a consultant Haematologist in the West of Scotland before moving to take up my present post based at Leeds Teaching Hospitals, in 2002.

I run a small peer-review grant-funded basic research group with areas of interests in transplantation and tumour immunology.

I am currently the President of the British Society of Blood & Marrow Transplantation. I represent the transplant society at the Government strategic and national commissioning level. I am a member of the NCRI Haematology-Oncology Clinical Studies Group. I am the secretary of the United Kingdom Myeloma Forum (UKMF) and have represented the interests of myeloma clinicians and patients in NICE reviews. I am a member of the NCRI Haem-Onc Myeloma sub-group and Principal Investigator for NCRI Myeloma X. In addition, I am a Board member of Myeloma UK and Medical Editor of Myeloma Today.